Increased market supply, slightly reduced vitamin B1 prices
Review of the domestic market in January and March
Because Huazhong Pharmaceutical is located in Xiangyang, Hubei, after the outbreak of the domestic epidemic in January, Huazhong Pharmaceutical has also been in production suspension and signing phase in March. The spot price of VB1 MONO soared in March, up to 40 USD KG; The supply of English labels is in short supply, and spot prices are rising.
The following figure shows the domestic weekly VB1 MONO price trend in 2020:

The current market situation
Since Brother Technology Co., Ltd., on March 13, the government issued a "Review of Jiangsu Brother Vitamin Co., Ltd. on the resumption of production." Starting in late March, the factory will resume production, and the market ’s bearish atmosphere has increased. In addition, many domestic regions Resumption of work and production began, Hubei began to unblock in late March, and Huazhong Pharmaceutical also resumed work. The orders placed by the factory in the previous period began to be shipped externally. Therefore, some traders were worried that the B1 market price would fall. Vitamin B1 has been sold at a low price. As of early April, most domestic VB1 MONO market prices are concentrated at about 33-35 USD/ KG, which is 5-7 USD / KG lower than the factory's direct price of 40 USD/ KG.
ECHEMI market forecast
According to the factory, although many industries in China have resumed work and production, the supply of raw materials for VB1 has not yet resumed, and most B1 factories have limited starts.
The following table shows the start of domestic factories:

At the same time, due to the severe form of foreign epidemics, many countries have begun to block countries, and export demand has decreased. Therefore, the domestic VB1 MONO market is currently in the stage of supply and demand games. It is not ruled out that some traders may sell in advance and continue to lower the VB1 price.
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Dafeng Haijianuo’s RMB 246 Million Technical Revamp Project Takes Shape, with Multiple Production Lines for Vitamin K1, Folic Acid, and Others Under Construction
-
Indonesian pharmaceutical company Biofarma announces the acquisition of US Pharma Lab
-
Personalized supplements startup VitaminLab raises series A financing
-
Market Analysis of Domestic Veterinary Drug Raw Materials in the 34th Week of 2022
-
Vitamin Market Analysis
-
Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022
-
Are More 'Vitamins' in The Feed the Better?
-
Vitamin Market Analysis
-
What do we need to pay attention to in order to regulate qi and blood with diet?
-
Analysis of Functional Food for Relieving Visual Fatigue And Its Functional Components
Recommend Reading
-
The “Counter-Wind Ledger” of CHF 11.2 Billion: Sika Barely Grew in 2025—Yet Kept Taking Market Share
-
Chemours Sells Its Former Titanium Dioxide Site in Taiwan: Turning a “White Powder” Factory into “Wind Power Real Estate” for $360 Million—Buying Not Cash, But Breathing Room
-
US Imposes Heavy Duties on Chinese L-Lysine with Combined Rates up to 188%
-
U.S. Chemical Companies Are Benefiting from This Feedstock Shock
-
Strait of Hormuz Reopens, Oil Prices Plunge: Is the Chemical Price Rally Over?
-
In August, the epoxy resins market in China remained stable within a narrow range with weak supply and demand on both sides
-
Business Society’s Market Outlook for Heavy-Weight Pure Soda Ash on September 1, 2026: Volatile
-
August Petrochemical Coke Market Trends: First Rise, Then Fall
-
Business Society’s September 1, 2026 Melamine Market Outlook: Clearly Upward Trend
-
Crude Oil Prices First Fall, Then Rise; Retail Prices of Refined Oil Products See First Increase Since 2026